These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17237272)

  • 1. MRP8/ABCC11 directly confers resistance to 5-fluorouracil.
    Oguri T; Bessho Y; Achiwa H; Ozasa H; Maeno K; Maeda H; Sato S; Ueda R
    Mol Cancer Ther; 2007 Jan; 6(1):122-7. PubMed ID: 17237272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCC11/MRP8 confers pemetrexed resistance in lung cancer.
    Uemura T; Oguri T; Ozasa H; Takakuwa O; Miyazaki M; Maeno K; Sato S; Ueda R
    Cancer Sci; 2010 Nov; 101(11):2404-10. PubMed ID: 20718756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites.
    Pratt S; Shepard RL; Kandasamy RA; Johnston PA; Perry W; Dantzig AH
    Mol Cancer Ther; 2005 May; 4(5):855-63. PubMed ID: 15897250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.
    Guo Y; Kotova E; Chen ZS; Lee K; Hopper-Borge E; Belinsky MG; Kruh GD
    J Biol Chem; 2003 Aug; 278(32):29509-14. PubMed ID: 12764137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression.
    Magdy T; Arlanov R; Winter S; Lang T; Klein K; Toyoda Y; Ishikawa T; Schwab M; Zanger UM
    Pharmacogenomics; 2013 Sep; 14(12):1433-48. PubMed ID: 24024896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.
    Uemura T; Oguri T; Maeno K; Sone K; Takeuchi A; Fukuda S; Kunii E; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Ito Y; Niimi A
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1229-1239. PubMed ID: 31529207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation.
    Liu J; Kolath J; Anderson J; Kolar C; Lawson TA; Talmadge J; Gmeiner WH
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):481-6. PubMed ID: 10555156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
    Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
    Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
    Honorat M; Mesnier A; Vendrell J; Guitton J; Bieche I; Lidereau R; Kruh GD; Dumontet C; Cohen P; Payen L
    Endocr Relat Cancer; 2008 Mar; 15(1):125-38. PubMed ID: 18310281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models.
    Honorat M; Terreux R; Falson P; Di Pietro A; Dumontet C; Payen L
    BMC Struct Biol; 2013 May; 13():7. PubMed ID: 23641929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.
    Nabeya Y; Suzuki T; Furuya A; Koide N; Ohkoshi M; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
    Cancer Sci; 2011 Aug; 102(8):1509-15. PubMed ID: 21561529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer.
    Delhorme JB; Bersuder E; Terciolo C; Vlami O; Chenard MP; Martin E; Rohr S; Brigand C; Duluc I; Freund JN; Gross I
    Biomed Pharmacother; 2022 Mar; 147():112630. PubMed ID: 35051860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
    Inaba M; Naoe Y; Mitsuhashi J
    Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
    Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
    Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.
    Liu J; Kolar C; Lawson TA; Gmeiner WH
    J Org Chem; 2001 Aug; 66(17):5655-63. PubMed ID: 11511236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
    Kawabata S; Oka M; Shiozawa K; Tsukamoto K; Nakatomi K; Soda H; Fukuda M; Ikegami Y; Sugahara K; Yamada Y; Kamihira S; Doyle LA; Ross DD; Kohno S
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1216-23. PubMed ID: 11162657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.
    Chung YM; Park S; Park JK; Kim Y; Kang Y; Yoo YD
    Cancer Lett; 2000 Oct; 159(1):95-101. PubMed ID: 10974411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.